OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma
Pavlina Chuntova, Akane Yamamichi, Tiffany Chen, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004644-e004644
Open Access | Times Cited: 26
Pavlina Chuntova, Akane Yamamichi, Tiffany Chen, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004644-e004644
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
IDH inhibition in gliomas: from preclinical models to clinical trials
Roberta Rudà, Craig Horbinski, Martin J. van den Bent, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 7, pp. 395-407
Closed Access | Times Cited: 23
Roberta Rudà, Craig Horbinski, Martin J. van den Bent, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 7, pp. 395-407
Closed Access | Times Cited: 23
Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity
Mengyuan Cai, Jianyi Zhao, Qiang Ding, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24454-e24454
Open Access | Times Cited: 7
Mengyuan Cai, Jianyi Zhao, Qiang Ding, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24454-e24454
Open Access | Times Cited: 7
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas
Alberto Pïcca, Mehdi Touat, Lisa Belin, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114034-114034
Closed Access | Times Cited: 4
Alberto Pïcca, Mehdi Touat, Lisa Belin, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114034-114034
Closed Access | Times Cited: 4
GBM immunotherapy: Exploring molecular and clinical frontiers
Mrinal K. Ghosh, Sunny Kumar, Sabana Begam, et al.
Life Sciences (2024) Vol. 356, pp. 123018-123018
Closed Access | Times Cited: 4
Mrinal K. Ghosh, Sunny Kumar, Sabana Begam, et al.
Life Sciences (2024) Vol. 356, pp. 123018-123018
Closed Access | Times Cited: 4
Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
Zhiyang Huang, Yingying Li, Hong Zhao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Zhiyang Huang, Yingying Li, Hong Zhao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
The Complexity of Malignant Glioma Treatment
Linde F. C. Kampers, Dennis S. Metselaar, Maria Vinci, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 879-879
Open Access
Linde F. C. Kampers, Dennis S. Metselaar, Maria Vinci, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 879-879
Open Access
Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
Marco Gallus, Darwin Kwok, Senthilnath Lakshmanachetty, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3726-3726
Open Access | Times Cited: 11
Marco Gallus, Darwin Kwok, Senthilnath Lakshmanachetty, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3726-3726
Open Access | Times Cited: 11
New insights into the Immune TME of adult-type diffuse gliomas
Quentin Richard, Alice Laurenge, Michel Mallat, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 6, pp. 794-802
Open Access | Times Cited: 14
Quentin Richard, Alice Laurenge, Michel Mallat, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 6, pp. 794-802
Open Access | Times Cited: 14
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas
Atsuro Saijo, Hirokazu Ogino, Nicholas Butowski, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 2, pp. 335-347
Closed Access | Times Cited: 8
Atsuro Saijo, Hirokazu Ogino, Nicholas Butowski, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 2, pp. 335-347
Closed Access | Times Cited: 8
Effects of metabolic cancer therapy on tumor microenvironment
Petra Hyroššová, Mirko Milošević, Josef Škoda, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Petra Hyroššová, Mirko Milošević, Josef Škoda, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
2-hydroxyglutarate rides the cancer-immunity cycle
Iosifina P. Foskolou, Lukas Bunse, Jan Van den Bossche
Current Opinion in Biotechnology (2023) Vol. 83, pp. 102976-102976
Open Access | Times Cited: 7
Iosifina P. Foskolou, Lukas Bunse, Jan Van den Bossche
Current Opinion in Biotechnology (2023) Vol. 83, pp. 102976-102976
Open Access | Times Cited: 7
Co-evolution of glioma and immune microenvironment
Mahmoud Elguindy, Jacob S. Young, Winson S. Ho, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e009175-e009175
Open Access | Times Cited: 2
Mahmoud Elguindy, Jacob S. Young, Winson S. Ho, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e009175-e009175
Open Access | Times Cited: 2
Metabolite-driven antitumor immunity
James A. Nathan
Science (2022) Vol. 377, Iss. 6614, pp. 1488-1489
Closed Access | Times Cited: 11
James A. Nathan
Science (2022) Vol. 377, Iss. 6614, pp. 1488-1489
Closed Access | Times Cited: 11
The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function
Iosifina P. Foskolou, Pedro P. Cunha, Elena Sánchez‐López, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113013-113013
Open Access | Times Cited: 6
Iosifina P. Foskolou, Pedro P. Cunha, Elena Sánchez‐López, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113013-113013
Open Access | Times Cited: 6
Prognostic biomarker prediction for glioma induced by heavy metals and their mixtures: An in-silico study
Hai Duc Nguyen
Toxicology and Applied Pharmacology (2022) Vol. 459, pp. 116356-116356
Closed Access | Times Cited: 10
Hai Duc Nguyen
Toxicology and Applied Pharmacology (2022) Vol. 459, pp. 116356-116356
Closed Access | Times Cited: 10
Glioma-neuronal circuit remodeling induces regional immunosuppression
Takahide Nejo, Saritha Krishna, Christian Jimenez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Takahide Nejo, Saritha Krishna, Christian Jimenez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
The IDH1-R132H mutation aggravates cisplatin-induced acute kidney injury by promoting ferroptosis through disrupting NDUFA1 and FSP1 interaction
Kunmei Lai, Zhimin Chen, Siyi Lin, et al.
Cell Death and Differentiation (2024)
Open Access | Times Cited: 1
Kunmei Lai, Zhimin Chen, Siyi Lin, et al.
Cell Death and Differentiation (2024)
Open Access | Times Cited: 1
Identification of heterogeneous subtypes and a prognostic model for gliomas based on mitochondrial dysfunction and oxidative stress-related genes
Junsheng Li, Siyu Wang, Xiaojing Chi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Junsheng Li, Siyu Wang, Xiaojing Chi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Targeting the IDH1R132H mutation in gliomas by CRISPR/Cas precision base editing
Remi Weber, Flavio Vasella, Artsiom Klimko, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access
Remi Weber, Flavio Vasella, Artsiom Klimko, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access
Exploring the Regulatory Mechanism of CXCL16 Molecule-Related Antigen Presentation Using lncRNA-mRNA Co-Expression Network Analysis
Tingting Liu, Shuai Zheng, Lixin Jia, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 11561-11575
Open Access
Tingting Liu, Shuai Zheng, Lixin Jia, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 11561-11575
Open Access
The oncometabolite D-2-hydroxyglutarate promotes DNA hypermethylation at lineage-specific enhancers controlling microglial activation in IDHmutgliomas
Alice Laurenge, Pietro Pugliese, Quentin Richard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alice Laurenge, Pietro Pugliese, Quentin Richard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Gaining Insight into the Catalytic Mechanism of the R132H IDH1 Mutant: A Synergistic DFT Cluster and Experimental Investigation
Joshua A. Broome, Nguyen Phong Nguyen, Cassidy R. E. Baumung, et al.
Biochemistry (2024)
Closed Access
Joshua A. Broome, Nguyen Phong Nguyen, Cassidy R. E. Baumung, et al.
Biochemistry (2024)
Closed Access
Comprehensive multicentre retrospective analysis for predicting isocitrate dehydrogenase‐mutant lower‐grade gliomas
Dongxu Zhao, Xin Lin, Tareq A. Juratli, et al.
Annals of Clinical and Translational Neurology (2024)
Open Access
Dongxu Zhao, Xin Lin, Tareq A. Juratli, et al.
Annals of Clinical and Translational Neurology (2024)
Open Access
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results
Alberto Pïcca, Gaetano Finocchiaro
Current Opinion in Oncology (2022) Vol. 34, Iss. 6, pp. 653-660
Closed Access | Times Cited: 2
Alberto Pïcca, Gaetano Finocchiaro
Current Opinion in Oncology (2022) Vol. 34, Iss. 6, pp. 653-660
Closed Access | Times Cited: 2
The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function
Iosifina P. Foskolou, Pedro P. Cunha, Eleanor Minogue, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Iosifina P. Foskolou, Pedro P. Cunha, Eleanor Minogue, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
